Overview

Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Assessing the efficacy of Celebrex premedication on pain during and after endodontic treatment in teeth with symptomatic irreversible pulpits
Phase:
N/A
Details
Lead Sponsor:
Cairo University
Treatments:
Celecoxib